It is particularly beneficial for cases of MiT/TFE tRCC that present with negative or equivocal pathological or clinical characteristics, as these can be further evaluated through the TFE3 FISH assay (14). The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.